Quick Search
Filters Clear All
Any Time
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Product Category
- Antibiotics
- Balanced Salt Solutions
- Cell Dissociation Reagents
- Cell Freezing Media
- Cell Health Assays
- Cell Identification Service
- Cell Lines
- Complete Growth Media
- Cytokines
- Exosome Isolation Kits
- Growth Supplements
- Induced Differentiation Media
- Liquid Basal Media
- Other Reagents
- Powder Basal Media
- Primary Cell Isolation and Culture Kit
- Primary Cells
- Removal Media
- Removal Reagents
- Serum
- Serum-Free Media
Country
- Angola
- Argentina
- Australia
- Austria
- Bangladesh
- Barbados
- Belarus
- Belgium
- Brazil
- Bulgaria
- Burkina Faso
- Burundi
- Cambodia
- Cameroon
- Canada
- Chile
- China
- Chinese Taiwan
- Congo
- Croatia
- Cyprus
- Czech
- Czechia
- Denmark
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Gabon
- Germany
- Ghana
- Greece
- Hungary
- India
- Indonesia
- Iran
- Iraq
- Ireland
- Israel
- Italy
- Japan
- Kazakhstan
- Kenya
- Korea
- Kuwait
- Kyrgyzstan
- Luxembourg
- Malaysia
- Mexico
- Mongolia
- Morocco
- Mozambique
- Myanmar
- Nepal
- Netherlands
- New Zealand
- Nigeria
- Norway
- Pakistan
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Saudi Arabia
- Singapore
- Slovenia
- Somalia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Thailand
- Tunisia
- Turkey
- UAE
- UK
- USA
- Uganda
- Ukraine
- United Kingdom
- Uruguay
- Uzbekistan
- Vietnam
Publications
Procell has assisted our customers in publishing 32,193 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.
Filter
-
HS3ST2, regulated by METTL14 through m6A mechanisms, contributes to M1 macrophage polarization in chronic obstructive pulmonary disease (2026-01-15)
Journal: Letters in Drug Design & Discovery (2026) IF: 1.6Products Cited: -
Development of novel pyridine containing acylhydrazones as anticancer agents that target VEGFR-2 in human breast cancer cells (2026-01-16)
Journal: Letters in Drug Design & Discovery (2026) IF: 1.6Products Cited: -
Exploring the mechanism of Squamocin inhibits oral squamous cell carcinoma malignant progression by targeting peroxisome proliferator activated receptor-gamma based on network pharmacology and molecular docking (2026-03-07)
Journal: Letters in Drug Design & Discovery (2026) IF: 1.6 -
15, 16-dihydrotanshinone I mitigates right ventricular hypertrophy in pulmonary arterial hypertension by suppressing HIF1A/CXCR4 signaling (2026-03-07)
Journal: Letters in Drug Design & Discovery (2026) IF: 1.6Products Cited: -
Unraveling the mechanisms of Phillyrin’s otoprotective effects: An integrated approach of network pharmacology and in vitro validation (2026-02-02)
Journal: Letters in Drug Design & Discovery (2026) IF: 1.6Products Cited: DMEM/F12 Medium -
Transcriptomic analysis combined with network pharmacology and molecular docking identifies NLRP3/SOD2 as potential targets of puerarin linked to macrophage polarization in lumbar disc herniation (2026-02-02)
Journal: Letters in Drug Design & Discovery (2026) IF: 1.6 -
Astaxanthin alleviates cerebral infarction by targeting MAPK14: insights from network pharmacology, Molecular Docking, and experimental validation (2026-05-05)
Journal: Letters in Drug Design & Discovery (2026) IF: 1.6Products Cited: Human Brain Microvascular Endothelial Cells -
Network pharmacology-based strategy to investigate pharmacological mechanisms of scutellaria baicalensis against aging (2026-02-13)
Journal: Letters in Drug Design & Discovery (2026) IF: 1.6Products Cited: DMEM (High glucose) Medium, Fetal Bovine Serum -
Shenqinlong Qingfei Peiyuan Keli alleviates inflammation, macrophage autophagy and M1 polarization via inhibiting HDAC2-mediated ULK1 deacetylation in pneumococcal pneumonia (2026-05-01)
Journal: Letters in Drug Design & Discovery (2026) IF: 1.6Products Cited: -
Unveiling biomarkers of chemoresistance: CASP1, ENG, and H6PD in 5-Fu-treated colorectal cancer (2026-03-19)
Journal: Letters in Drug Design & Discovery (2026) IF: 1.6
